PAM
CPRX

Panagora Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Panagora Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,780
Closed -$10K – 1858
2021
Q2 		$10K Sell
1,780
-7,363
-81% -$38K ﹤0.01% 2251
2021
Q1 		$42K Sell
9,143
-7,266
-44% -$28.9K ﹤0.01% 2210
2020
Q4 		$55K Sell
16,409
-1,159
-7% -$3.89K ﹤0.01% 2022
2020
Q3 		$52K Hold
17,568
– – ﹤0.01% 2004
2020
Q2 		$81K Hold
17,568
– – ﹤0.01% 1850
2020
Q1 		$67K Sell
17,568
-239,171
-93% -$982K ﹤0.01% 1814
2019
Q4 		$963K Sell
256,739
-43,314
-14% -$203K ﹤0.01% 1067
2019
Q3 		$1.59M Buy
300,053
+2,815
+0.9% +$15K 0.01% 836
2019
Q2 		$1.14M Hold
297,238
– – 0.01% 1077
2019
Q1 		$1.52M Sell
297,238
-312,811
-51% -$920K 0.01% 954
2018
Q4 		$1.17M Sell
610,049
-1,401
-0.2% -$4.01K 0.01% 1008
2018
Q3 		$2.31M Buy
611,450
+333,821
+120% +$1.05M 0.01% 787
2018
Q2 		$866K Buy
277,629
+222,885
+407% +$676K ﹤0.01% 1192
2018
Q1 		$131K Buy
+54,744
New +$182K ﹤0.01% 1789
2015
Q4 		– Sell
-15,023
Closed -$45K – 2313
2015
Q3 		$45K Sell
15,023
-58,988
-80% -$255K ﹤0.01% 2018
2015
Q2 		$306K Sell
74,011
-50,388
-41% -$201K ﹤0.01% 1505
2015
Q1 		$539K Buy
+124,399
New +$448K ﹤0.01% 1292

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Panagora Asset Management's CPRX Position: Q3 2021 in Review

Panagora Asset Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2021, closing a stake of 1,780 shares — an estimated $10K sold.

Panagora Asset Management first reported a position in CPRX in Q1 2015 and held it in 17 quarters. The position peaked at $2.31M in Q3 2018. 144 funds tracked by Wall St. Rank hold CPRX as of Q3 2021.

  • Panagora Asset Management reported no remaining Catalyst Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 1,780 Catalyst Pharmaceutical shares in Q3 2021, an estimated $10K.
  • Panagora Asset Management first reported a position in Catalyst Pharmaceutical in Q1 2015 and held it in 17 quarters.
  • Panagora Asset Management's Catalyst Pharmaceutical position peaked at $2.31M in Q3 2018.
  • 144 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.